早期胃癌保留胃手术的生活质量与营养结局:SENORITA随机临床试验的二次分析
本研究为SENORITA随机临床试验的二次分析,比较保留胃手术与标准胃切除术的长期生活质量和营养结局。共纳入194例保留胃手术患者和257例标准胃切除术患者,保留胃手术组在术后3个月多项生活质量评分更优,术后1年体重指数、血红蛋白、白蛋白和蛋白水平更高。
要点
- 保留胃手术组术后3个月躯体功能、呼吸困难、食欲丧失、吞咽困难、进食受限、焦虑、味觉改变和体象评分优于标准胃切除术组。
- 术后1年保留胃手术组体重指数(23.9 vs 22.1)及血红蛋白(14.3 vs 13.3 g/dL)、白蛋白(4.3 vs 4.25 g/dL)、蛋白(7.3 vs 7.1 g/dL)水平高于标准胃切除术组。
- 在保留胃手术组中,肿瘤位于胃大弯和下部与术后3个月整体健康状况、反流和进食受限相关。
核心结论
- 经前哨淋巴结评估后的保留胃手术与标准胃切除术相比,与更好的长期生活质量和营养结局相关,这些发现可能有助于早期胃癌患者的治疗决策。
研究设计与样本
- 本研究为SENORITA随机临床试验的二次分析,该试验比较腹腔镜前哨淋巴结导航手术(LSNNS)与腹腔镜标准胃切除术(LSG)。
- 患者来自韩国7家三级或综合医院,2013年3月至2016年12月入组,随访至5年,数据分析于2022年8月至9月进行。
- 纳入LSG组中实际接受腹腔镜标准胃切除术的患者和LSNNS组中接受保留胃手术的患者,排除未完成基线或任何随访问卷的患者。
- 共纳入194例保留胃手术患者和257例标准胃切除术患者,平均(标准差)年龄55.6(10.6)岁,男性249例(55.2%)。
主要发现
- 保留胃手术组术后3个月躯体功能(87.2 vs 83.9)、呼吸困难(5.9 vs 11.2)、食欲丧失(13.1 vs 19.4)、吞咽困难(8.0 vs 12.7)、进食受限(10.9 vs 18.2)、焦虑(29.0 vs 35.2)、味觉改变(7.4 vs 13.0)和体象(19.5 vs 27.2)评分优于标准胃切除术组。
- 术后1年保留胃手术组体重指数(23.9 vs 22.1,体重公斤数除以身高米数平方)和血红蛋白(14.3 vs 13.3 g/dL)、白蛋白(4.3 vs 4.25 g/dL)、蛋白(7.3 vs 7.1 g/dL)水平显著高于标准胃切除术组。
- 在保留胃手术组中,多变量分析显示肿瘤位置(胃大弯、下部)与术后3个月整体健康状况(β,10.5;95%CI,3.2至17.8)、反流(β,-8.4;95%CI,-14.7至-2.1)和进食受限(β,-5.7;95%CI,-10.3至-1.0)有利相关。
- 节段性切除与术后3年腹泻风险(β,40.6;95%CI,3.1至78.1)和进食受限(β,15.1;95%CI,1.1至29.1)相关。
临床怎么用
- 原文未据此给出推荐,仅指出经前哨淋巴结评估后的保留胃手术与更好的长期生活质量和营养结局相关,这些发现可能有助于早期胃癌患者的治疗决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The Sentinel Node Oriented Tailored Approach (SENORITA) randomized clinical trial evaluated quality of life (QoL) and nutritional outcomes between the laparoscopic sentinel node navigation surgery (LSNNS) and laparoscopic standard gastrectomy (LSG). However, there has been no report on the QoL and nutritional outcomes of patients who underwent stomach-preserving surgery among the LSNNS group. OBJECTIVE: To compare long-term QoL and nutritional outcomes between patients who underwent stomach-preserving surgery and those who underwent standard gastrectomy and to identify factors associated with poor QoL outcomes in patients who underwent stomach-preserving surgery. DESIGN, SETTING, AND PARTICIPANTS: This study is a secondary analysis of the SENORITA trial, a randomized clinical trial comparing LSNNS with LSG. Patients from 7 tertiary or general hospitals across the Republic of Korea were enrolled from March 2013 to December 2016, with follow-up through 5 years. Data were analyzed between August and September 2022. Among trial participants, patients who underwent actual laparoscopic standard gastrectomy in the LSG group and those who underwent stomach-preserving surgery in the LSNNS group were included. Patients who did not complete the baseline or any follow-up questionnaire were excluded. INTERVENTION: Stomach-preserving surgery vs standard gastrectomy. MAIN OUTCOMES AND MEASURES: Overall European Organization for Research and Treatment of Cancer QoL Questionnaire Core 30 (EORTC QLQ-C30) and stomach module (STO22) scores, body mass index, hemoglobin, protein, and albumin levels. RESULTS: A total of 194 and 257 patients who underwent stomach-preserving surgery and standard gastrectomy, respectively, were included in this study (mean [SD] age, 55.6 [10.6] years; 249 [55.2%] male). The stomach-preserving group had better QoL scores at 3 months postoperatively in terms of physical function (87.2 vs 83.9), dyspnea (5.9 vs 11.2), appetite loss (13.1 vs 19.4), dysphagia (8.0 vs 12.7), eating restriction (10.9 vs 18.2), anxiety (29.0 vs 35.2), taste change (7.4 vs 13.0), and body image (19.5 vs 27.2). At 1 year postoperatively, the stomach-preserving group had significantly higher body mass index (23.9 vs 22.1, calculated as weight in kilograms divided by height in meters squared) and hemoglobin (14.3 vs 13.3 g/dL), albumin (4.3 vs 4.25 g/dL), and protein (7.3 vs 7.1 g/dL) levels compared to the standard group. Multivariable analyses showed that tumor location (greater curvature, lower third) was favorably associated with global health status (β, 10.5; 95% CI, 3.2 to 17.8), reflux (β, -8.4; 95% CI, -14.7 to -2.1), and eating restriction (β, -5.7; 95% CI, -10.3 to -1.0) at 3 months postoperatively in the stomach-preserving group. Segmental resection was associated with risk of diarrhea (β, 40.6; 95% CI, 3.1 to 78.1) and eating restriction (β, 15.1; 95% CI, 1.1 to 29.1) at 3 years postoperatively. CONCLUSIONS AND RELEVANCE: Stomach-preserving surgery after sentinel node evaluation was associated with better long-term QoL and nutritional outcomes than standard gastrectomy. These findings may help facilitate decision-making regarding treatment for patients with early-stage gastric cancer. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01804998.
引用
- Eom BW, Yoon HM, Kim YW, et al. Quality of Life and Nutritional Outcomes of Stomach-Preserving Surgery for Early Gastric Cancer: A Secondary Analysis of the SENORITA Randomized Clinical Trial. JAMA Surg. 2024. PMID: 38809537. doi:10.1001/jamasurg.2024.1210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。